Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size.
暂无分享,去创建一个
F. Barone | E. Ohlstein | R. F. White | A M Romanic | R F White | A J Arleth | E H Ohlstein | F C Barone | A. M. Romanic | A. Arleth | R. White | V. L. Dawson
[1] L. Pitts,et al. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. , 1986, Stroke.
[2] L. Liotta,et al. Metastatic potential correlates with enzymatic degradation of basement membrane collagen , 1980, Nature.
[3] J. Enghild,et al. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. , 1992, The Journal of biological chemistry.
[4] G. Hamann,et al. Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion. , 1995, Stroke.
[5] F. Barone,et al. Subtractive cloning identifies tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) increased gene expression following focal stroke. , 1998, Stroke.
[6] L. Matrisian. The matrix‐degrading metalloproteinases , 1992, Journal of neuro-oncology.
[7] J. Cossins,et al. Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-α inhibitor , 1997, Journal of Neuroimmunology.
[8] R. Willette,et al. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. , 1997, Stroke.
[9] L. Matrisian,et al. Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. , 1994, Invasion & metastasis.
[10] Y. Shiga,et al. Correlation Between Myeloperoxidase‐Quantified Neutrophil Accumulation and Ischemic Brain Injury in the Rat: Effects of Neutrophil Depletion , 1994, Stroke.
[11] R A Swanson,et al. A Semiautomated Method for Measuring Brain Infarct Volume , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[12] U. Moll,et al. Inhibition of matrix metalloproteinase 9 activation by a specific monoclonal antibody. , 1993, Hybridoma.
[13] E. Goetzl,et al. Matrix metalloproteinases in immunity. , 1996, Journal of immunology.
[14] Z. Werb,et al. Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. , 1986, The Journal of biological chemistry.
[15] G. Godeau,et al. Action of proteolytic and glycolytic enzymes on the permeability of the blood-brain barrier. , 1974, Biomedicine / [publiee pour l'A.A.I.C.I.G.].
[16] Gary A. Rosenberg,et al. Proteolytic Cascade Enzymes Increase in Focal Cerebral Ischemia in Rat , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[17] Y. Itoh,et al. Steps Involved in Activation of the Pro-matrix Metalloproteinase 9 (Progelatinase B)-Tissue Inhibitor of Metalloproteinases-1 Complex by 4-Aminophenylmercuric Acetate and Proteinases (*) , 1995, The Journal of Biological Chemistry.
[18] A. M. Romanic,et al. Extracellular Matrix‐Degrading Proteinases in the Nervous System , 1994, Brain pathology.
[19] L. Liotta,et al. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation , 1991, Cell.
[20] Teng-Nan Lin,et al. Effect of Brain Edema on Infarct Volume in a Focal Cerebral Ischemia Model in Rats , 1993, Stroke.
[21] B. Siesjö,et al. Mechanisms of ischemic brain damage , 1988, Critical care medicine.
[22] P. Kochanek,et al. Polymorphonuclear Leukocytes and Monocytes/Macrophages in the Pathogenesis of Cerebral Ischemia and Stroke , 1992, Stroke.
[23] M J Banda,et al. Secretion of metalloproteinases by stimulated capillary endothelial cells. I. Production of procollagenase and prostromelysin exceeds expression of proteolytic activity. , 1986, The Journal of biological chemistry.
[24] A. Dayton. The Rev Axis of HIV-1 and Its Associated Host Cofactors: A Viral Window onto the Workings of Eukaryotic Posttranscriptional RNA Processing. , 1996, Journal of biomedical science.
[25] Z. Werb,et al. Vectorial secretion of extracellular matrix proteins, matrix-degrading proteinases, and tissue inhibitor of metalloproteinases by endothelial cells. , 1990, The Journal of biological chemistry.
[26] L. Liotta,et al. Injury-induced 92-kilodalton gelatinase and urokinase expression in rat brain. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[27] P. Gottschall,et al. Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons. , 1996, Neuroimmunomodulation.
[28] F. Barone,et al. Development of tissue damage, inflammation and resolution following stroke: An immunohistochemical and quantitative planimetric study , 1993, Brain Research Bulletin.
[29] W. Risau,et al. Development of the blood-brain barrier , 1990, Trends in Neurosciences.
[30] J. Woessner,et al. Matrix metalloproteinases and their inhibitors in connective tissue remodeling , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[31] M. Moskowitz,et al. Emerging treatments for stroke in humans. , 1996, Trends in pharmacological sciences.
[32] P. Libby,et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. , 1994, The Journal of clinical investigation.
[33] M. Hendrix,et al. The 72 kDa type IV collagenase is modulated via differential expression of alpha v beta 3 and alpha 5 beta 1 integrins during human melanoma cell invasion. , 1993, Cancer research.
[34] H. Sarau,et al. Time-related changes in myeloperoxidase activity and leukotriene B4 receptor binding reflect leukocyte influx in cerebral focal stroke. , 1995, Molecular and chemical neuropathology.
[35] A. M. Romanic,et al. The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent , 1994, The Journal of cell biology.
[36] P. Libby,et al. Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[37] M. Cowan,et al. American Heart Association. , 2018, P & T : a peer-reviewed journal for formulary management.
[38] G. Rosenberg. Matrix metalloproteinases in brain injury. , 1995, Journal of neurotrauma.
[39] U. K. Laemmli,et al. Cleavage of structural proteins during , 1970 .
[40] R. Willette,et al. Genetic hypertension and increased susceptibility to cerebral ischemia , 1992, Neuroscience & Biobehavioral Reviews.